Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

FDA Tainted-Products Program and Enforcement

The Hidden-Drug Supplement Problem

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
CDER Health Fraud / Tainted Products database; post-market warnings and recalls

Reference only. Not medical advice.

What can go wrong

Undeclared sildenafil/tadalafil can cause dangerous hypotension in men taking nitrates and bypasses the medical screening that a prescription provides. Undeclared steroids carry the cardiovascular, hepatic, and endocrine risks of unmonitored AAS use. A 'supplement' label is no assurance of drug-free content.

This is something to take to a clinician. The Atlas can tell you what is known about fda tainted-products program and enforcement in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

The FDA's Center for Drug Evaluation and Research maintains a Tainted Products Marketed as Dietary Supplements database tracking products found to contain undeclared, FDA-unapproved drug ingredients. The pattern is stark: sexual-enhancement 'supplements' are most often spiked with sildenafil or tadalafil (the active drugs in Viagra and Cialis), weight-loss products with sibutramine, and muscle-building products with synthetic steroids. One analysis found unapproved pharmaceutical ingredients in 776 supplements flagged from 2007 through 2016.

Most 'natural' enhancement pills FDA tested were spiked with the very drugs they avoid naming.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Identifies hidden-drug 'supplements' for consumer warning
  • Documents the sexual-enhancement adulteration pattern
  • Supports recalls and import alerts

How it works

Because DSHEA bars pre-market approval, FDA relies on post-market surveillance: lab testing of marketed products, adverse-event signals, and import screening. When a 'supplement' is found to contain an undeclared drug, FDA issues a public notification and seeks a voluntary recall; the agency generally cannot pre-empt sale. Independent research has reproduced the problem, multiple surveys have found large fractions of sexual-enhancement supplements adulterated with PDE5 inhibitors.

Why the hidden-drug problem is structural, not occasional

The adulteration is not random contamination, it is the point. A 'natural' pill that secretly contains sildenafil actually works, which drives repeat sales, while the 'all-natural' label evades both the prescription requirement and the drug-approval process. DSHEA's post-market-only posture means FDA is perpetually reacting: it must detect, test, and warn after products are already in consumers' hands. Hidden sildenafil is especially dangerous because it can interact catastrophically with nitrate medications, exactly the interaction prescription labeling exists to prevent.

What people get wrong

  • Often said'All natural' enhancement pills contain no drugs

    ActuallyFDA testing repeatedly finds undeclared sildenafil or tadalafil in such products, the 'natural' label is often the cover.

  • Often saidFDA screens supplements before sale

    ActuallyFDA acts post-market; it tests and warns after products are already being sold.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Program
FDA CDER Tainted Products database / Health Fraud notifications
Sexual-enhancement adulterant
Most often undeclared sildenafil or tadalafil
Muscle-building adulterant
Synthetic/designer steroids
Flagged products (2007-2016)
776 supplements with unapproved drug ingredients (published analysis)
Enforcement tool
Public warnings, voluntary recalls; DSHEA limits pre-market control

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about FDA Tainted-Products Program and Enforcement. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Unapproved pharmaceutical ingredients in supplements (JAMA Network Open analysis)2018

    776 supplements (2007-2016) carried unapproved drug ingredients; sildenafil dominated sexual-enhancement products

  • Survey of adulterated sexual-enhancement productsvarious

    Large fractions tested positive for undeclared PDE5 inhibitors